Skip to main content

Table 2 Prevalence of elevated hemoglobin A1c and the number needed to screen at the time of HIV testing according to national screening guidelines

From: Clinic-based diabetes screening at the time of HIV testing and associations with poor clinical outcomes in South Africa: a cohort study

Outcome

Noutcome/Ntotal

%

NNS

% hyperglycemic cases identified

% hyperglycemic cases missed

Overall

 Diabetes (HbA1c ≥ 6.5%)

26/1207

2.2

46.5

100

0

 Hyperglycemia (HbA1c ≥ 5.7%)

239/1207

19.8

5.1

100

0

Age ≥ 45 years

 Diabetes (HbA1c ≥ 6.5%)

10/143

7.0

14.3

38.5

61.5

 Hyperglycemia (HbA1c ≥ 5.7%)

45/143

31.5

3.1

18.8

80.3

BMI ≥ 25 kg/m2

 Diabetes (HbA1c ≥ 6.5%)

19/685

2.8

36.0

73.1

26.9

 Hyperglycemia (HbA1c ≥ 5.7%)

153/685

22.3

4.5

64.0

36.0

Age ≥ 45 years and/or BMI ≥ 25 kg/m2

 Diabetes (HbA1c ≥ 6.5%)

20/729

2.7

36.5

76.9

23.1

 Hyperglycemia (HbA1c ≥ 5.7%)

163/729

22.4

4.5

68.2

31.8

  1. BMI body mass index, HbA1c hemoglobin A1c, NNS number needed to screen